Diastolic heart failure in the community

Current Cardiology Reports

Volumn 2, Issue 5, 2000, Pages 461-469

  Hart, Chari Y T ^a   Redfield, Margaret M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE HEART FAILURE; DIASTOLE; DISEASE COURSE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW;

DIASTOLE; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; PREVALENCE; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034268543     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-000-0061-y     Document Type: Article

References (39)

1. Graves EG, Gillum BS: 1994 Summary: National Hospital Discharge Survey: advance data. National Center for Health Statistics 1996, 278:1-12.
2. O'Connell JB, Bristow MR: Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994, 13:S107-S112.
3. Gillum RF: Epidemiology of heart failure in the United States. Am Heart J 1993, 126:1042-1047.
4. Senni M, Tribouilloy CM, Rodeheffer RJ, et al.: Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998, 98:2282-2289.
5. Vasan RS, Larson MG, Benjamin EJ, et al.: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a populationbased cohort. J Am Coll Cardiol 1999, 33:1948-1955.
6. Setaro JF, Soufer R, Remetz MS, et al.: Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol 1992, 69:1212-1216.
7. European Study Group on Diastolic Heart Failure: How to diagnose diastolic heart failure. European Heart Journal 1998, 19:990-1003.
8. Lainchbury JG, Redfield MM: Doppler echocardiographicguided diagnosis and therapy of heart failure. Curr Cardiol Reports 1999, 1:55-66.
9. Cheng C-P, Noda T, Nozawa T, Little WC: Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow. Circ Res 1993, 72:795-806.
10. Kitzman DW, Higginbotham MB, Cobb FR, et al.: Exercise intolerance in patients with heart failure and preserved left ventricular systolic function - failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17:1065-1072.
11. Brutsaert DL, Sys SU: Diastolic dysfunction in heart failure. J Card Failure 1997, 3:225-242.
12. McKee PA, Castelli WD, McNamara PM, et al.: The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 26:1441-1446.
13. Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25:305-313.
14. Kannel WB, Belanger AJ: Epidemiology of heart failure. Am Heart J 1991, 121:951-957.
15. Vasan RS, Benjamin EJ, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565-1574.
16. Dougherty AH, Naccarelli GV, Gray EL, et al.: Congestive heart failure with normal systolic function. Am J Cardiol 1984, 54:778-782.
17. Soufer R, Wohlgelernter D, Vita NA, et al.: Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985, 55:1032-1036.
18. Cohn JN, Johnson G: Heart failure with normal ejection fraction - the V-HeFT study. Circulation 1990, 81(suppl III): III-48-III-53.
19. Thomas JT, Kelly RF, Thomas SJ, et al.: History, physical exam, ECG, and chest x-ray do not differentiate normal from decreased systolic function in patients with congestive heart failure [abstract]. Circulation 1999, 100(18):I-381.
20. The SAVE Investigators: Effect of captopril on mortality and morbidity in patients with ventricular dysfunction after myocardial infarction - Results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992, 327:669-677.
21. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:293-302.
22. McDonagh TA, Morrison CE, Lawrence A, et al.: Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997, 350(9081):829-833.
23. Redfield MM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ: Isolated diastolic dysfunction in the community [abstract]. Circulation 1999, 100(18) (suppl):I-381.
24. Rich MW: Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997, 45:968-974.
25. Frohlich ED, Apstein C, Chobanian AV, et al.: The heart in hypertension. N Engl J Med 1992, 327(14):998-1008.
26. Cuocolo A, Sax FL, Brush JE, et al.: Left ventricular hypertrophy and impaired diastolic filling in essential hypertension - diastolic mechanisms for systolic dysfunction during exercise. Circulation 1990, 81:978-986.
27. Meissner I, Whisnant JP, Sheps SG, et al.: Detection and control of high blood pressure in the community: do we need a wake-up call? Hypertension 1999, 34:466-471.
28. Levy D, Larson MG, Vasan RS, et al.: The progression from hypertension to congestive heart failure. JAMA 1996, 275(20):1557-1562.
29. Yamamoto K, Wilson DJ, Canzanello VJ, Redfield MM: Left ventricular diastolic dysfunction in patients with hypertension and preserved systolic function. Mayo Clin Proc 2000, 75:148-155.
30. Setaro JF, Zaret BL, Schulman DS, et al.: Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990, 66:981-986.
31. Aldigier JC, Huang H, Dalmay F, et al.: Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol 1993, 21:289-295.
32. Warner JG, Metzger DC, Kitzman DW, Wesley DJ, Little WC: Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999, 33:1567-1572.
33. Topol EJ, Traill TA, Fortuin NJ: Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985, 312:277-283.
34. Shah AM, Spurgeon HA, Sollott SJ, et al.: 8-bromo-cGMP reduces the myofilament response to calcium in intact cardiac myocyte. Circ Res 1994, 74:970-978.
35. Yamamoto K, Burnett JC Jr., Redfield MM: Effect of the endogenous natriuretic peptide system on ventricular and coronary function in the failing canine heart. Am J Physiol 1997, 273:H2406-H2414.
36. Lainchbury JG, Burnett JC Jr., Redfield MM: Effect of the natriuretic peptides on load and myocardial function in normal and heart failure dogs. Am J Physiol 2000, in press.
37. Teramae CY, Hahn EL, Burnett JC Jr., et al.: Regulation of systolic and diastolic function by endogenous cGMP in experimental heart failure [abstract]. J Am Coll Cardiol 2000, in press.
38. Clarkson PBM, Wheeldon NM, MacFadyen RJ, et al.: Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation 1996, 93:2037-2042.
39. Parmley WW: Do we practice geriatric cardiology [editorial]? J Am Coll Cardiol 1997, 29:217-218.